Found 4091 with Last Name = 'gadhachanda' and Initial = 'vr' 
Affinity DataIC50: 100nMAssay Description:Beta-Lactamase inhibitory activity against representativeclass C (P99) serine enzymeMore data for this Ligand-Target Pair
TargetMetallo-beta-lactamase L1 type 3(Stenotrophomonas maltophilia)
Southern Methodist University
Curated by ChEMBL
Southern Methodist University
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of class B (BCII) metallo-beta-lactamase representative enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 122nMAssay Description:Beta-Lactamase inhibitory activity against representative class A (TEM-1) serine enzymeMore data for this Ligand-Target Pair
TargetMetallo-beta-lactamase L1 type 3(Stenotrophomonas maltophilia)
Southern Methodist University
Curated by ChEMBL
Southern Methodist University
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Beta-Lactamase Inhibition of metallo-beta-lactamase representative class B (L1) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Beta-Lactamase Inhibition of metallo-beta-lactamase representative class B (L1) enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: 650nMAssay Description:Beta-Lactamase inhibitory activity against representative class A (TEM-1) serine enzymeMore data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
